The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2022

Filed:

Jun. 23, 2017
Applicant:

Osiris Therapeutics, Inc., Columbia, MD (US);

Inventors:

Steven Michael Sinclair, Ellicott City, MD (US);

Alla Danilkovitch, Columbia, MD (US);

Malathi Sathyamoorthy, Ellicott City, MD (US);

Jin-Qiang Kuang, Glenelg, MD (US);

Sandeep Dhall, Elkridge, MD (US);

Yishan Liu, Doylestown, PA (US);

Anthony John Melchiorri, Ellicott City, MD (US);

Matthew Robert Moorman, Chestertown, MD (US);

Mena Schiano Lo Moriello, Silver Spring, MD (US);

Anne Allgood Lerch, Annapolis, MD (US);

Assignee:

OSIRIS THERAPEUTICS, INC., Columbia, MD (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/50 (2015.01); A61K 35/51 (2015.01); A01N 1/02 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/19 (2006.01); A61K 35/33 (2015.01); A61P 19/00 (2006.01); A61P 19/04 (2006.01); A61P 17/02 (2006.01); A61P 29/00 (2006.01); A61P 19/10 (2006.01); A61P 19/02 (2006.01); A61L 27/36 (2006.01); A61L 27/38 (2006.01); A61L 26/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/50 (2013.01); A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 9/0024 (2013.01); A61K 9/06 (2013.01); A61K 9/19 (2013.01); A61K 35/33 (2013.01); A61K 35/51 (2013.01); A61L 26/0057 (2013.01); A61L 27/3604 (2013.01); A61L 27/3834 (2013.01); A61P 17/02 (2018.01); A61P 19/00 (2018.01); A61P 19/02 (2018.01); A61P 19/04 (2018.01); A61P 19/10 (2018.01); A61P 29/00 (2018.01);
Abstract

Disclosed are compositions comprising a non-homogenized chorionic matrix, a homogenized amniotic matrix and a homogenized UC (UC) matrix, wherein the non-homogenized chorionic matrix comprises viable cells. Disclosed are methods of making the compositions disclosed herein comprising preparing a non-homogenized chorionic matrix, preparing a homogenized amniotic matrix, preparing a homogenized UC matrix, and combining the non-homogenized chorionic matrix, the non-homogenized chorionic matrix, and the homogenized UC matrix. Disclosed are methods of treating a tissue injury or chronic pain comprising administering any of the disclosed compositions to an area of a subject comprising a tissue injury.


Find Patent Forward Citations

Loading…